Screener
OS Therapies OSTX Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by OS Therapies in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: OS Therapies’s 10-Q, filed May 18, 2026.
- Filed
- May 18, 2026, 6:02 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-058070
| Line item | For the Three Months Ended / March 31, 2026 | For the Three Months Ended / March 31, 2025 |
|---|---|---|
| Interest expense | (75,344) | - |
| Non-operating expenses | (153,594) | - |
| Change in fair value of warrant liability | - | 1,122,561 |
| TOTAL OTHER (EXPENSE) INCOME | (228,893) | 1,122,627 |
| NET LOSS | (10,396,831) | (3,876,859) |
| NET LOSS available to common shareholders | $(10,396,831) | $(3,876,859) |
| Weighted-average # of shares | 38,674,663 | 21,249,423 |
| Basic and diluted loss per common share outstanding | $(0.27) | $(0.18) |
Item 1. Consolidated Financial Statements.
FAQ
- What is OS Therapies's net income?
- OS Therapies (OSTX) reported net income of -$10.4M in Q1 2026.
- How has OS Therapies's net income changed year-over-year?
- OS Therapies's net income decreased by 168.2% year-over-year, from -$3.88M to -$10.4M.
- What is the long-term trend for OS Therapies's net income?
- Over 2 years (2023 to 2025), OS Therapies's net income has grown at a 92.1% compound annual growth rate (CAGR), from -$7.79M to -$28.75M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about OS Therapies's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude